skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

The Lancet (British edition), 2024-03, Vol.403 (10432), p.1153-1163 [Peer Reviewed Journal]

2024 Elsevier Ltd ;Copyright © 2024 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)02577-1 ;PMID: 38461843

Full text available

Citations Cited by

Sign in to Post Your Review

Sign in to Add New Tags

Searching Remote Databases, Please Wait